{"title":"Mitochondrial translation deficiency limits the cardiac benefit of ketogenic diet in early-onset cardiomyopathy.","authors":"Ozlem Kartal, Sukru Anil Dogan","doi":"10.1007/s10863-026-10143-9","DOIUrl":"10.1007/s10863-026-10143-9","url":null,"abstract":"<p><p>Mitochondrial cardiomyopathy is a devastating disorder with no effective treatment. Ketogenic diet (KD) has shown therapeutic benefit in some mitochondrial disease models but failed or caused harm in others, suggesting its efficacy depends on the underlying genetic defect. KD has ameliorated cardiomyopathy in models where the electron transport chain retains structural integrity, yet it has not been tested in a model with a primary defect in mitochondrial translation. We therefore examined KD in heart- and skeletal muscle-specific Dars2 knockout mice (hmKO), a model of fatal early-onset mitochondrial cardiomyopathy caused by loss of mitochondrial aspartyl-tRNA synthetase, which is essential for translation of all 13 mitochondrial DNA-encoded oxidative phosphorylation subunits. Male hmKO mice and wild type littermates received either a ketogenic or normal chow diet from weaning until the humane endpoint. KD induced a partial shift toward cardiac fatty acid metabolism and activated mitochondrial biogenesis signaling. However, these adaptations did not improve survival, cardiac hypertrophy, skeletal muscle atrophy, motor performance, respiratory chain complex abundance, enzyme activities, or cardiac ATP levels. KD reduced antioxidant gene expression, without increasing protein carbonylation, and amplified the mitokine response, with increased GDF15 and FGF21 in the heart and serum. These findings show that substrate availability alone cannot restore cardiac bioenergetics when mitochondrial translation capacity is severely impaired. Instead, mitochondrial translation machinery defines a critical boundary for metabolic interventions in mitochondrial cardiomyopathy. Our results argue that the therapeutic potential of KD in mitochondrial disease is mechanism-dependent and should not be generalized across genetically and bioenergetically distinct forms of mitochondrial cardiomyopathy.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Revitalizing aging muscles: harnessing NAD⁺, sirtuins, and exercise to combat sarcopenia.","authors":"Yan Wang, Guimei Zhang","doi":"10.1007/s10863-026-10140-y","DOIUrl":"10.1007/s10863-026-10140-y","url":null,"abstract":"<p><p>Aging is associated with systemic metabolic dysfunction that contributes to geriatric syndromes such as sarcopenia-the progressive loss of skeletal muscle mass and function. Evidence from preclinical models suggests that age-associated depletion of nicotinamide adenine dinucleotide (NAD⁺) may contribute to this decline by limiting the activity of sirtuin deacetylases (SIRT1-7). These enzymes act as metabolic sensors regulating mitochondrial biogenesis, oxidative capacity, DNA repair and pathways related to muscle atrophy. Physical exercise enhances NAD⁺ salvage through upregulation of nicotinamide phosphoribosyltransferase (NAMPT). Pharmacological approaches including NAD⁺ precursor supplementation (nicotinamide riboside or nicotinamide mononucleotide) and inhibition of NAD⁺-consuming enzymes have shown benefits in preclinical models. However, clinical translation remains inconsistent. Recent meta-analyses have found no significant effect of these precursors on muscle mass or strength in adults aged over 60 years. Moreover, experimental evidence indicates that even profound NAD⁺ depletion in adult mouse skeletal muscle does not necessarily compromise function or accelerate aging. We conclude that pharmacological NAD⁺ restoration alone is currently insufficient to reverse sarcopenia in humans. A synergistic approach combining exercise with targeted NAD⁺ support, together with emerging strategies involving precursor transporters, trigonelline and hypothalamic NAD⁺-sirtuin circuits, represents a testable avenue that requires rigorous, stratified clinical evaluation.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of uridine on cardiomyocyte mitochondrial function in SHR in the early stage of hypertension.","authors":"E Yu Talanov, N V Khmil, N I Venediktova","doi":"10.1007/s10863-026-10142-w","DOIUrl":"10.1007/s10863-026-10142-w","url":null,"abstract":"<p><p>The development of heart failure due to hypertension is known to be accompanied by various mitochondrial dysfunctions. It has previously been established that the pyrimidine nucleoside uridine (U) exerts a protective effect on the structural and functional parameters of mitochondria under various pathological conditions. This study aimed to evaluate the functional state of mitochondria in spontaneously hypertensive rats (SHR) in the stage of the early hypertension and to investigate the effect of uridine on mitochondrial dysfunction associated with this pathology. A 30-mg/kg uridine was found not to affect blood pressure (BP) dynamics in SHR and WKY (Wistar Kyoto) animals. In SHR, the levels of thiobarbituric acid-reactive substances (TBARS) in serum increased compared to WKY. SHR cardiac mitochondria showed decrease in respiratory control ratio compared to WKY mitochondria. Injection of uridine was accompanied by a respiratory rate decrease in the SHR + U group relative to the control. Uridine increased the levels of respiratory complexes IV and V subunits in SHR. The rate of H<sub>2</sub>O<sub>2</sub> generation in SHR cardiac mitochondria to be restored to the control levels after uridine administration. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities in SHR decreased; herewith, uridine caused no statistically significant changes in SOD, GPx, and catalase (CAT) activities. This nucleoside was found not to affect the levels of mitochondrial ATP-sensitive potassium channel (MITOK) subunits in both animal strains studied. Thus, uridine exhibited antioxidant effects, contributing to partial normalization of cardiac mitochondrial function in SHR in the early stages of hypertension. This was probably due to modulation of the activity of mitochondrial transport systems, without the risk of hypertensive effects. These data justify further research into uridine as a cardiomyocyte protector. Hypertension, mitochondrial dysfunctions, uridine, oxidative stress, MITOK, SHR rats, OXPHOS.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149267654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaoli Zhang, Yingge Wang, Li Xu, Yuxiang Sun, Xingyi Wang, Wei Wang
{"title":"Upregulation of ZBTB20 indirectly participate in ferroptosis of Parkinson's disease by neuronal glial interactions.","authors":"Xiaoli Zhang, Yingge Wang, Li Xu, Yuxiang Sun, Xingyi Wang, Wei Wang","doi":"10.1007/s10863-026-10131-z","DOIUrl":"10.1007/s10863-026-10131-z","url":null,"abstract":"<p><p>Parkinson's Disease (PD) is an age- associated late-onset neurodegenerative disorder characterized by typical dysfunction and diverse non-motor complications, which severely impair the quality of life of elderly patients. The present study systematically investigated the biological function, diagnostic value, and underlying molecular mechanisms of zinc finger and BTB domain-containing 20 (ZBTB20) in the pathological progression of PD. Both transcriptional and translational analyses demonstrated significant upregulation of ZBTB20 expression in in vivo PD mouse models and in vitro PD cellular models. Functional cellular experiments revealed that ZBTB20 overexpression markedly promoted mitochondrial reactive oxygen species (ROS) accumulation and aggravated oxidative stress in PD cell lines, whereas ZBTB20 knockdown exerted the opposite protective effects. Consistent with the in vitro observations, in vivo striatal injection of sh-ZBTB20 effectively alleviated pathological lesions and mitigated ROS-mediated oxidative damage in PD mice. Further mechanistic validation from in vitro and in vivo experiments confirmed that ZBTB20 upregulation facilitates ferroptosis during PD progression. Notably, pharmacological activation of ferroptosis completely abolished the motor protective phenotypes induced by ZBTB20 silencing in PD mice, verifying the critical involvement of ferroptosis in ZBTB20-mediated PD pathogenesis. Mechanistic exploration revealed that ZBTB20 knockdown significantly elevated the protein abundance of large tumor suppressor kinase 1 (LATS1) in PD models. Co-immunoprecipitation assays further validated a direct physical interaction between ZBTB20 and LATS1. Specifically, ZBTB20 promotes LATS1 ubiquitination and subsequent proteasomal degradation in vitro. Moreover, pharmacological inhibition of LATS1 effectively reversed the inhibitory effect of ZBTB20 knockdown on microglial ferroptosis in PD models. In conclusion, ZBTB20 exacerbates mitochondrial oxidation- dependent ferroptosis to accelerate PD progression via negatively regulating LATS1 signaling. Targeted inhibition of ZBTB20 therefore represents a promising and actionable therapeutic strategy for the clinical treatment of PD.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xianpeng Ma, Jing Liu, Xiao Shao, Yupeng Huang, Guangyao Hu
{"title":"Mitofusin 2 orchestrates mitochondrial metabolic homeostasis and suppresses cutaneous squamous cell carcinoma by stabilizing ER-mitochondria contacts.","authors":"Xianpeng Ma, Jing Liu, Xiao Shao, Yupeng Huang, Guangyao Hu","doi":"10.1007/s10863-026-10132-y","DOIUrl":"10.1007/s10863-026-10132-y","url":null,"abstract":"<p><p>This study aimed to elucidate the biological role of Mitofusin 2 (Mfn2) in cutaneous squamous cell carcinoma (cSCC) and evaluate how its regulation of mitochondria-associated membranes (MAMs) may suppress tumor progression by reshaping mitochondrial metabolic homeostasis and apoptosis. We compared Mfn2 expression between normal keratinocytes (HaCaT) and cSCC cells (A431), establishing a stable Mfn2-overexpressing (Mfn2-OE) A431 model. Structural impacts on ER-mitochondrial contacts and MAMs were evaluated using immunofluorescence, STED super-resolution microscopy, TEM, and subcellular fractionation (VDAC1/IP3R/Grp75). Functional assays assessed ER-mitochondrial calcium transport (probes), lipid peroxidation/ROS (C11-BODIPY/DCFH-DA), mitochondrial membrane potential, and ATP levels (JC-1/ATP assays). Mitochondria-dependent apoptosis (Bcl-2/p53/Cytochrome c/Caspase-3) was analyzed via flow cytometry, TUNEL, and Western blot. Phenotypes were assessed using CCK-8, EdU, colony formation, and Transwell assays. In vivo xenografts in nude mice were monitored, with H&E/IHC analysis. Proteomics and untargeted metabolomics (LC-MS) were performed (n = 6/group). Mfn2 protein levels were lower in A431 cSCC cells than in HaCaT keratinocytes. Mfn2-OE enhanced ER-mitochondrial contacts, increased MAMs, and stabilized the VDAC1-Grp75-IP3R complex. This enhanced calcium transport, reduced ROS/lipid peroxidation, stabilized MMP, and decreased ATP. Mfn2-OE inhibited Bcl-2, promoted p53 mitochondrial translocation and Cytochrome c release, activating Caspase cascades. Both in vitro and in vivo, Mfn2-OE suppressed proliferation, invasion, and tumor growth. Proteomics/metabolomics revealed metabolic reprogramming involving energy metabolism, lipid metabolism, and redox balance. Mfn2 may act as a tumor-suppressive regulator in the A431 cSCC model by stabilizing MAMs, remodeling mitochondrial metabolic homeostasis, and activating mitochondria-dependent apoptosis.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149194144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of aquatic exercise on nociceptive behavior, systemic inflammation, and skeletal muscle redox status in healthy and reserpine-treated rats.","authors":"Arife Apaydın Pınar, Muaz Belviranli, Nilsel Okudan","doi":"10.1007/s10863-026-10139-5","DOIUrl":"10.1007/s10863-026-10139-5","url":null,"abstract":"<p><p>This study investigated whether a 21-day swimming exercise protocol administered concurrently with reserpine exposure modifies nociceptive behavior, serum serotonin and TNF-α levels, and skeletal muscle redox markers in a reserpine-induced fibromyalgia (FM) model. Twenty-four female rats were randomly allocated into Control (CON), Reserpine (RES), Exercise (EX), and RES + EX groups. FM was induced via subcutaneous reserpine administration (1 mg kg<sup>-1</sup> day<sup>-1</sup> for 3 days). Swimming groups exercised for 60 min day<sup>-1</sup> over 21 days. Behavioral hyperalgesia was evaluated using the cold-plate test. Serum tumor necrosis factor-alpha (TNF-α) and serotonin, alongside skeletal muscle malondialdehyde (MDA), protein carbonyl (PC), superoxide dismutase (SOD), glutathione (GSH), and total antioxidant capacity (TAC) were quantified using ELISA. Compared with CON, the RES group showed shorter cold-plate latency, lower serum serotonin, higher serum TNF-α, higher muscle PC, and lower muscle SOD and GSH (p ≤ 0.05). MDA was higher in RES than in EX and RES + EX, but a significant difference between RES and CON was not reported. Swimming increased cold-plate latency in RES + EX compared with RES on days 7, 14, and 21 (all p < 0.001). RES + EX also showed higher serotonin and lower TNF-α than RES (p ≤ 0.05). Muscle PC was lower and SOD/GSH were higher in RES + EX than in RES for the reported comparisons; however, GSH remained lower in RES + EX than in EX. TAC did not differ significantly among groups (p = 0.228). Swimming exercise attenuated reserpine-associated cold allodynia and was associated with more favorable serum serotonin/TNF-α profiles and skeletal muscle redox markers.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149182006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shentao Lu, Xueru Yang, Yingxia He, Hua Linghu, Xuemei Fu
{"title":"APPL1 attenuates DHEA-induced oxidative injury in granulosa cells by enhancing mitophagy and suppressing ferroptosis: implications for polycystic ovary syndrome.","authors":"Shentao Lu, Xueru Yang, Yingxia He, Hua Linghu, Xuemei Fu","doi":"10.1007/s10863-026-10141-x","DOIUrl":"10.1007/s10863-026-10141-x","url":null,"abstract":"<p><p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder frequently associated with granulosa cell dysfunction. However, its underlying molecular mechanisms remain unclear. Therefore, we aimed to examine the role of APPL1 in PCOS and determine whether it attenuates oxidative stress and ferroptosis by modulating mitophagy in granulosa cells. An in vitro PCOS model was established by treating KGN cells with dehydroepiandrosterone (DHEA), with or without concurrent APPL1 overexpression. An in vivo PCOS rat model was established by DHEA injection, followed by intraovarian lentiviral delivery to overexpress APPL1. Oxidative stress, ferroptosis, and mitophagy markers were also evaluated. Mdivi-1, the DRP1/mitochondrial fission inhibitor, was used to examine this pathway. APPL1 expression was significantly reduced in DHEA-treated KGN cells and PCOS rat ovaries. APPL1 overexpression markedly attenuated DHEA-induced oxidative stress and ferroptosis in vitro, as evidenced by reduced ROS, MDA, 8‑OHdG, Fe²⁺, and ACSL4 levels, together with restored antioxidant enzyme activities and GPX4/SLC7A11 expression. Concurrently, APPL1 overexpression enhanced mitophagy, as shown by an increased LC3-II/LC3-I ratio and decreased p62 and TOMM20/COX IV levels. Treatment with Mdivi-1 attenuated these protective effects. APPL1 overexpression improved estrous cyclicity, attenuated hyperandrogenism, ameliorated ovarian morphology, and alleviated ovarian oxidative stress and ferroptosis in PCOS rats. APPL1 protected granulosa cells against DHEA-induced oxidative injury and ferroptosis by enhancing mitophagy in preclinical PCOS models. These findings provide mechanistic insights into PCOS pathogenesis and identify the APPL1-mitophagy axis as a potential target for PCOS intervention.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Integrated bioinformatics analysis, machine learning, and experimental validation reveal that ACSL1 drives myocardial ischemia reperfusion injury via ferroptosis.","authors":"Shuiling Yuan, Zhong Xie, Chunchen Xia, Shiqi Yang, Jiming Zhou","doi":"10.1007/s10863-026-10138-6","DOIUrl":"10.1007/s10863-026-10138-6","url":null,"abstract":"<p><p>Myocardial ischemia-reperfusion injury (MIRI) is a significant factor in the development of cardiac dysfunction following an acute myocardial infarction (AMI). Ferroptosis, a type of regulated cell death driven by iron and marked by lipid peroxidation, has attracted increasing attention for its pivotal role in the pathogenesis of MIRI. It has been reported that acyl-CoA synthetase long chain family member 1 (ACSL1), a ferroptosis promoter, could mediate ferroptosis of myocardial cells during AMI. However, the specific function and mechanism of ACSL1 in AMI are still unclear. Differentially expressed genes in AMI were identified from the Gene Expression Omnibus (GEO) databases (GSE166780 and GSE97320), and ferroptosis-related genes were acquired from the PathCards database. Through integrated analysis of the two genomes, ferroptosis-related genes in AMI were identified. Then, the identified genes were subjected to cross-validation using three machine learning algorithms (LASSO, SVM-RFE, and RF), ultimately identifying characteristic genes. ACSL1, Forkhead box protein O4 (FOXO4), tripartite motif-containing protein 25 (TRIM25), and GPX4 protein levels were detected using western blot. Cell viability and apoptosis were Cell Counting Kit-8 (CCK-8) and flow cytometry. Interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) levels were analyzed using enzyme-linked immunosorbent assay (ELISA). Fe2+ level, lipid reactive oxygen species (ROS) level, and GSH level were examined using commercial kits. Flow cytometric analysis of mitochondrial membrane potential using JC-1. Binding between FOXO4 and ACSL1 promoter was predicted by JASPAR and verified using dual-luciferase reporter and ChIP assays. The stability of ACSL1 was assessed by CHX assay. Interaction between TRIM25 and ACSL1 was verified using Co-immunoprecipitation (CoIP) assay. The effect of ACSL1 on myocardial injury was detected using a mouse MIR model. After screening and identification, ferroptosis-related gene ACSL1 in AMI was selected for this study. ACSL1 expression was increased in AMI patients and Ischemia/Reperfusion (H/R)-treated AC16 cells. H/R-triggered AC16 cell viability inhibition, and apoptosis, inflammatory response, ferroptosis, and mitochondrial dysfunction promotion were partly abolished by ACSL1 silencing. Mechanistically, FOXO4 activated ACSL1 transcription by binding to its promoter region. TRIM25 facilitated ACSL1 ubiquitination and decreased its protein stability. ACSL1 downregulation could relieve myocardial damage in vivo. ACSL1 was identified as a key ferroptosis-related gene in AMI. Furthermore, FOXO4-activated transcription and TRIM25-mediated ubiquitination-dependent degradation of ACSL1 could affect H/R-induced cardiomyocyte damage and ferroptosis, providing a promising therapeutic target for MIRI treatment.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"M2-Exo-derived miR-1227-5p protects against periodontitis through inhibiting USP2-dependent deubiquitination of Drp1.","authors":"Danwei Zhao, Ruifeng Li, Nan Li","doi":"10.1007/s10863-026-10137-7","DOIUrl":"10.1007/s10863-026-10137-7","url":null,"abstract":"<p><p>Periodontitis is a common chronic inflammatory disease with an exaggerated host immune response. M2 type macrophages exert protective properties in periodontitis. This study aimed to investigate the role of M2-Exo-derived miR-1227-5p in periodontitis. M2-Exo were verified using TEM and NTR assay. miRNA and mRNA levels were determined using RT-qPCR. periodontal ligament stem cells (PDLCs) were exposed to LPS in establish in vitro periodontitis model. Gene expression was determined using Western blot and immunofluorescence. The binding sites of miR-1227-5p on USP2 were predicted by TargetScan and verified by luciferase, RNA pull-down, and RIP assays. Deubiquitination of Drp1 was determined using in vitro ubiquitination assay. Cellular behaviors of PDLCs were analyzed by CCK-8, alizarin red staining, and ALP staining. LPS exposure induced mitochondrial dysfunction and suppressed the osteogenesis of PDLCs. M2-Exo-derived miR-1227-5p improved mitochondrial function and promoted the proliferation and osteogenesis of PDLCs. miR-1227-5p directly targeted USP2. USP2 overexpression reversed the effects of miR-1227-5p and improved mitochondrial function and the osteogenesis of PDLCs. Moreover, miR-1227-5p targeted USP2 to inhibit the deubiquitination of Drp1, improving mitochondrial function. Furthermore, M2-Exo-derived miR-1227-5p alleviates periodontitis via regulating USP2/Drp1. Therefore, M2-Exo hold great potential for future clinical applications.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"FTO-mediated GPX4 m6A modification in ferroptosis-induced DNA damage and inflammatory response during acute lung injury.","authors":"Xiuli Liu, Ying Gu, Fang Yuan","doi":"10.1007/s10863-026-10133-x","DOIUrl":"10.1007/s10863-026-10133-x","url":null,"abstract":"<p><p>To investigate the role of Fat Mass and Obesity-associated Protein (FTO) in acute lung injury (ALI) and elucidate how it regulates ferroptosis via N6-methyladenosine (m6A) modification of glutathione peroxidase 4 (GPX4). ALI models were established in LPS‑stimulated BEAS‑2B cells and mice. FTO expression was modulated by siRNA, inhibitors, or adeno‑associated virus. Ferroptosis, apoptosis, inflammation and DNA damage were assessed by RIP‑qPCR, meRIP‑qPCR, Western blotting and TEM. GPX4 m6A site mutants were constructed. GPX4 mRNA/protein stability and translation were analyzed using actinomycin D and cycloheximide. Establish an LPS-induced ALI mouse model, perform adeno-associated viral knockdown of FTO in lung tissue, and validate in vivo using GPX4 inhibitors. FTO inhibition significantly attenuated LPS-induced ferroptosis, apoptosis, inflammatory responses, and mitochondrial damage. Mechanistically, FTO accelerates GPX4 protein degradation by reducing m6A modification of GPX4, thereby downregulating GPX4 protein expression in a post-transcriptional and post-translational manner. This leads to intracellular iron accumulation, ROS bursts, lipid peroxidation, and DNA damage. Mutating the m6A site in GPX4 or supplementing GPX4 protein effectively reverses the aforementioned damage. Silencing FTO in vivo significantly ameliorates pulmonary tissue pathology, impaired lung function, ferroptosis, and inflammatory responses in mice via a GPX4-dependent pathway, whereas GPX4 inhibition reverses this protective effect. FTO exacerbates ALI by mediating m6A modification of GPX4 and downregulates its protein expression, thereby driving ferroptosis and DNA damage. Targeting the FTO-GPX4 axis may offer novel therapeutic strategies for ALI.</p>","PeriodicalId":15080,"journal":{"name":"Journal of Bioenergetics and Biomembranes","volume":"58 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148982818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}